Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
about
Lamotrigine for schizophreniaReplication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerImpact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approachesTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateKetamine for treatment-resistant unipolar depression: current evidenceThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaMeta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophreniaChronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient miceThe effectiveness of anticonvulsants in psychiatric disordersLooking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.The effects of ketamine and risperidone on eye movement control in healthy volunteers.Advances in the treatment of anxiety: targeting glutamate.Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration.Brain mechanisms of hallucinogens and entactogens.N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit.Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.Glutamate-mediated excitotoxicity in schizophrenia: a review.Do the dissociative side effects of ketamine mediate its antidepressant effects?Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.A review of the nonmedical use of ketamine: use, users and consequences.Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidenceA randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeuticsCinnarizine has an atypical antipsychotic profile in animal models of psychosis.Lamotrigine update and its use in mood disorders.Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.Glutamatergic model psychoses: prediction error, learning, and inferenceDepersonalization disorder: pharmacological approaches.Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).Emerging targets for the treatment of depressive disorder.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorderKetamine as a promising prototype for a new generation of rapid-acting antidepressants.Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugsEthanol-like effects of thiopental and ketamine in healthy humans.
P2860
Q24243946-5B1AF597-D8A7-4D58-8535-08C76C35AFE5Q24629398-EA77A07E-9CD9-446F-94BE-995C3FD5D557Q24630153-C3822747-CAC6-41C7-8F28-2A9BADEF266DQ26777966-57DED3C5-6E7B-456C-A623-F7F4E2133400Q26830533-4B6B30CA-C94B-4A3F-A26A-18E5BE055CFDQ26864324-CA619C8E-B795-409E-85D4-B31E47C000A5Q27004490-0D9B72DD-ED97-400E-A463-9EE8587A403AQ27004508-F8D58AB0-8D26-4704-A415-DCF34DB4E1DCQ28081110-D480C858-E95A-4D3F-8877-B512EBAF6A75Q28248687-4376C3EA-8649-44E1-9581-BA8673ADE2DEQ28539744-D6AF8FEB-ADB1-45A0-956F-189FE4F60BD1Q28744504-D83CEE9F-346B-4931-A30C-93F807C2D1E7Q30402789-2C743208-05ED-4A7D-8D1D-678ACE78F1AAQ30437913-DEDB14BE-DCAC-4E35-ADCA-BB4253CABCB8Q30457479-A7B9A2CE-1388-443A-95D6-4F9375812F78Q30458051-48C9D5E3-E507-4D0F-A34D-AD60B275413AQ30473430-4709A249-6C81-4184-A6F3-164A8B6144CCQ30474021-272504A4-B85E-491A-9937-676B6645FD03Q30478344-8FF41528-3C45-46B9-9945-C094290E549DQ30712278-D2A07236-5BA3-4AF9-932D-2218A9AC25E1Q30845062-1A58FE88-6361-4122-97C9-8A4293D09992Q33787133-AFCC03E9-2F0D-410B-9C71-835A5CCEBCB2Q33936354-109BDC51-4382-4989-B777-0AF8225890FCQ34157734-9B9FEE75-50A0-47F2-95D4-A53495884AF8Q34235541-16DFF5CB-09AA-40B8-90E9-A04926B92E27Q34315128-27705389-E496-409F-BD5D-F55AC20D36D6Q34367584-941850FA-1A7F-4691-9B56-9B970A39D6CFQ34444632-C003B308-7418-4F11-AADD-E31A256B2628Q34558887-4EE12A00-22DA-45AD-96B5-2B8308B56F2BQ34615607-F9D36C57-B5A4-4AC1-8BEF-0726B43060FDQ34622392-38CFA789-4C03-4537-878A-A0A5CF7BAECAQ34661231-1EBE7E7E-F28B-4744-BD19-5BE7BAB4C562Q34726919-E7775C53-659E-4839-8F96-AA7E9088C0FAQ34728943-3C9C57B8-95E8-4304-86E6-D2BA44E60E00Q35050432-01C25618-FB33-4428-ACFC-B69AF50B6972Q35476477-4FEEDE52-4D65-4B6C-92B9-D695EA6BB77CQ35547495-3BA90AD3-2DDC-4EBE-BA6A-296A55AF4090Q35770190-008A1396-6E01-43B2-98E2-940D78F637AAQ35792783-F374DCC1-0377-4FDF-BED0-FD7D61851994Q35794858-24FB1E0E-1CEB-4B2F-AA91-C87E9FBE2B91
P2860
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@en
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@nl
type
label
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@en
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@nl
prefLabel
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@en
Attenuation of the neuropsychi ...... spartate receptor antagonists.
@nl
P2093
P1433
P1476
Attenuation of the neuropsychi ...... aspartate receptor antagonists
@en
P2093
P304
P356
10.1001/ARCHPSYC.57.3.270
P407
P50
P577
2000-03-01T00:00:00Z